stocktools
Dilution profile // every instrument, one screen, from SEC filings

Guardian Pharmacy Services, Inc. (GRDN)

CIK 1802255 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$169M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
NOT COMPUTEDunder 3 years of share history on file
= share count now vs 3 years ago
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Fewer than two cover-page share counts on file, so there is no history to chart.

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $169.2Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3ASRMay 6, 2026fee exhibit found but no total offering amount (fees deferred, typical for automatic shelves)filing →
S-3MEFMar 19, 2026$27.9M registeredfiling →
S-3Oct 14, 2025$141.3M registeredfiling →

Last 12 months: 2 executed · 3 registered.

REGISTEREDMay 6, 2026Automatic shelf registration — effective immediately (large filers)S-3ASR →
EXECUTEDMar 20, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
REGISTEREDMar 19, 2026S-3MEF registration — capacity to sell shares, not a sale yetS-3MEF →
EXECUTEDMar 18, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
UPDATENov 4, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
REGISTEREDOct 14, 2025S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDMay 23, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EFFECTIVEMay 22, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 20, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDSep 30, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
REGISTEREDSep 26, 2024S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EXECUTEDSep 26, 2024Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full GRDN workspace